TSE:GUD FY2027 EPS Raised by Raymond James Financial
Knight Therapeutics Inc. (TSE:GUD – Free Report) – Stock analysts at Raymond James Financial increased their FY2027 earnings per share estimates for Knight Therapeutics in a research report issued on Wednesday, June 18th. Raymond James Financial analyst M. Freeman now anticipates that the company will post earnings per share of $0.17 for the year, up […]
Knight Therapeutics Inc. (TSE:GUD – Free Report) – Stock analysts at Raymond James Financial increased their FY2027 earnings per share estimates for Knight Therapeutics in a research report issued on Wednesday, June 18th. Raymond James Financial analyst M. Freeman now anticipates that the company will post earnings per share of $0.17 for the year, up […]
